These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 549016)

  • 1. Are circulating immune complexes and complement breakdown products useful for the detection of disease activity in nephrology?
    Coppo R; Giacchino F; Alloatti S; Quarello F; Segoloni G; Bossi P; Vercellone A; Piccoli G
    Proc Eur Dial Transplant Assoc; 1979; 16():709-10. PubMed ID: 549016
    [No Abstract]   [Full Text] [Related]  

  • 2. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.
    Perrin LH; Lambert PH; Miescher PA
    J Clin Invest; 1975 Jul; 56(1):165-76. PubMed ID: 1141431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of circulating immune complexes by the C1q complement fraction deviation test. 1st application in the study of human glomerulopathies].
    Sobel A; Gabay Y; Lagrue G
    Nouv Presse Med; 1976 Jun; 5(23):1465-9. PubMed ID: 132639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The complement system and nephritis.
    Müller-Eberhard HJ
    Adv Nephrol Necker Hosp; 1974; 4():3-14. PubMed ID: 4143384
    [No Abstract]   [Full Text] [Related]  

  • 5. Application of the solid phase C1q and Raji cell radioimmune assays for the detection of circulating immune complexes in glomerulonephritis.
    Tung KS; Woodroffe AJ; Ahlin TD; Williams RC; Wilson CB
    J Clin Invest; 1978 Jul; 62(1):61-72. PubMed ID: 659639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and clinical significance of circulating immune complexes in glomerulonephritis.
    Valentijn RM; Daha MR; Van Es LA
    Neth J Med; 1984; 27(9):340-9. PubMed ID: 6392910
    [No Abstract]   [Full Text] [Related]  

  • 7. Circulating complement breakdown products in patients with rheumatoid arthritis. Correlation between plasma C3d, circulating immune complexes, and clinical activity.
    Nydegger UE; Zubler RH; Gabay R; Joliat G; Karagevrekis CH; Lambert PH; Miescher PA
    J Clin Invest; 1977 May; 59(5):862-8. PubMed ID: 853126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.
    Baatrup G; Jonsson H; Sjöholm A; Sturfelt G; Svehag SE
    J Clin Lab Immunol; 1988 Jun; 26(2):73-9. PubMed ID: 3264027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of circulating immune complexes, C3 and C4 complement components and anti-DNA antibody in different classes of lupus nephritis.
    Klein MH; Thorner PS; Yoon SJ; Poucell S; Baumal R
    Int J Pediatr Nephrol; 1984 Jun; 5(2):75-82. PubMed ID: 6333404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of levels of circulating immune complexes to histologic patterns of nephritis: a comparative study of membranous glomerulonephropathy and diffuse proliferative glomerulonephritis.
    Ooi YM; Ooi BS; Pollak VE
    J Lab Clin Med; 1977 Nov; 90(5):891-8. PubMed ID: 908876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating immune complexes and serum immunoglobulins in acute poststreptococcal glomerulonephritis.
    Rodríguez-Iturbe B; Carr RI; García R; Rabideau D; Rubio L; McIntosh RM
    Clin Nephrol; 1980 Jan; 13(1):1-4. PubMed ID: 7363511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terminal complement complex in plasma from patients with systemic lupus erythematosus and other glomerular diseases.
    Horigome I; Seino J; Sudo K; Kinoshita Y; Saito T; Yoshinaga K
    Clin Exp Immunol; 1987 Nov; 70(2):417-24. PubMed ID: 3427827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum and glomerular complement in 205 cases of glomerulonephritis.
    Durante A; Rovati C; di Belgiojoso GB; Minetti L
    Proc Eur Dial Transplant Assoc; 1976; 12():189-96. PubMed ID: 935112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlations between complement degradation products and circulating immune complexes in human glomerulonephritis].
    Coppo R; De Marchi M; Alloatti S; Segoloni G; Giacchino F; Quarello F; Roccatello D; Bulzomi MR; Piccoli G
    Minerva Nefrol; 1979; 26(3):243-50. PubMed ID: 318057
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies of complement, nephritic factor, and circulating immune complexes in chronic mesangiocapillary glomerulonephritis types I and II (author's transl)].
    Mirapeix E; Yagüe J; Vives J; Revert L
    Med Clin (Barc); 1981 Jun; 77(1):21-6. PubMed ID: 7253758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical value of serum immune complexes in human glomerulonephritis.
    Schena FP; Losuriello V; Pertosa G; Penza R
    Ric Clin Lab; 1980; 10(1):99-105. PubMed ID: 7466167
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune complexes in schistosomiasis IV. C3, C4 and C1q characterization and correlation between C3 in serum and circulating IC levels.
    Santoro F; Bout D; Camus D; Capron A
    Rev Inst Med Trop Sao Paulo; 1977; 19(1):39-42. PubMed ID: 897474
    [No Abstract]   [Full Text] [Related]  

  • 18. Activation of complement in human nephritis.
    Lambert PH; Perrin LH; Mahieu P; Nydegger UE; Miescher PA
    Adv Nephrol Necker Hosp; 1974; 4():79-90. PubMed ID: 4220001
    [No Abstract]   [Full Text] [Related]  

  • 19. [Detection of circulating immune complexes by immunoenzyme assay with solid phase Clq].
    Mezzano S; López MI
    Rev Med Chil; 1984 Jun; 112(6):547-52. PubMed ID: 6393265
    [No Abstract]   [Full Text] [Related]  

  • 20. Complement deposition in glomerular diseases.
    di Belgiojoso GB; Tarantino A; Durante A; Guerra L
    Proc Eur Dial Transplant Assoc; 1975; 11():515-21. PubMed ID: 1105561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.